Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1999
06/10/1999WO1999028474A2 Chemokine variants and methods of use
06/10/1999WO1999028473A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
06/10/1999WO1999028472A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
06/10/1999WO1999028471A2 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE
06/10/1999WO1999028470A1 G-protein coupled receptors and uses therefor
06/10/1999WO1999028469A1 Compositions and methods for inducing gene expression
06/10/1999WO1999028468A1 Modulating b lymphocyte chemokine/receptor interactions
06/10/1999WO1999028467A1 Human thyroid protein zsig45 and dna encoding same
06/10/1999WO1999028466A1 Compositions and methods of use of het
06/10/1999WO1999028465A2 Pias molecules that recognize and bind stat proteins and uses thereof
06/10/1999WO1999028464A2 Cdnas and proteins belonging to the bhlh-pas superfamily of transcription regulators and methods of use
06/10/1999WO1999028463A2 Methods for the degradation and detoxification of organic material using urine produced by transgenic animals
06/10/1999WO1999028462A2 Polypeptides and nucleic acids encoding the same
06/10/1999WO1999028461A2 Methods and means for inducing apoptosis by interfering with bip-like proteins
06/10/1999WO1999028460A2 Molecules interacting with apoptin
06/10/1999WO1999028459A1 Examination method, examination reagent and remedy for diseases caused by variation in lkb1 gene
06/10/1999WO1999028458A1 Gene originating in human fetal chondrocytes
06/10/1999WO1999028457A1 Tsa305 gene
06/10/1999WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999WO1999028455A1 Method for preparing polypeptides with appropriate glycosilation
06/10/1999WO1999028454A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
06/10/1999WO1999028453A2 Transgenic non-human mammals with an oncogenic mutant of raf gene 1
06/10/1999WO1999028452A1 Matrilysin antisense compounds
06/10/1999WO1999028451A1 Cloning method by multiple digestion, vectors for implementing same and applications
06/10/1999WO1999028450A1 Method for facilitating the introduction of material into cells or structures
06/10/1999WO1999028449A2 Yac vectors
06/10/1999WO1999028448A1 Thermostable glucoamylase
06/10/1999WO1999028447A1 Human rnase h and compositions and uses thereof
06/10/1999WO1999028446A2 Branched chain amino acid biosynthetic enzymes
06/10/1999WO1999028440A1 Nucleic acid encoding mammalian ubr1
06/10/1999WO1999028439A2 Erythrovirus and its applications
06/10/1999WO1999028349A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
06/10/1999WO1999028348A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
06/10/1999WO1999028346A1 Erythropoietin with high specific activity
06/10/1999WO1999028344A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/10/1999WO1999028342A2 Low-voltage activated calcium channel compositions and methods
06/10/1999WO1999028335A1 Secreted proteins and polynucleotides encoding them
06/10/1999WO1999027958A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999WO1999027944A1 Prevention and treatment of amyloidogenic disease
06/10/1999WO1999016891B1 Methods of replicating virus in monocyte-derived macrophage cultures
06/10/1999WO1999015698A3 Method for synthesising and amplifying nucleic acids
06/10/1999WO1999015684A3 Expression of genes in hematopoietic stem cells in hischaemic conditions
06/10/1999WO1999015669A3 Clostridium toxin, and method for preparing immunogenic compositions
06/10/1999WO1999015659A3 Human ubiquitin-conjugating enzymes
06/10/1999WO1999015658A3 Human regulatory molecules
06/10/1999WO1999015643A3 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE
06/10/1999WO1999014331A3 Cyclin-dependent kinase inhibitors and uses thereof
06/10/1999WO1999014316A3 Synthetic hybrid plant promoter
06/10/1999WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/10/1999WO1999013073A3 Viral vector system capable of expressing an apoptosis-associated gene
06/10/1999WO1999013067A3 Hypoxia inducible promoter
06/10/1999WO1999012950A9 Improvements in or relating to stability of plant starches
06/10/1999WO1999011801A3 Protease based gene switching system
06/10/1999WO1999011764A3 Methods for generating high titer helper-free preparations of recombinant aav vectors
06/10/1999WO1999010375A3 Vaccine against hpv
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999WO1999006545A8 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
06/10/1999WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
06/10/1999DE19810349A1 Nucleic acid encoding bacterial chitin deacetylase useful for generating chitosan
06/10/1999DE19754622A1 Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität Herbal GntI sequences and use thereof for the production of plants with reduced or lacking N-acetylglucosaminyltransferase I (GnT) activity
06/10/1999DE19753350A1 Mutant formate dehydrogenase (FDH) from Candida boidinii for production of L-amino acids
06/10/1999CA2408167A1 Pro243 polypeptides and nucleic acids encoding the same
06/10/1999CA2313243A1 Nucleic acid encoding mammalian ubr1
06/10/1999CA2313014A1 Methods for the detection of chromosomal aberrations
06/10/1999CA2312920A1 Prevention and treatment of amyloidogenic disease
06/10/1999CA2312478A1 G-protein coupled receptors and uses therefor
06/10/1999CA2312379A1 A bacterial multi-hybrid system and applications
06/10/1999CA2312290A1 Secreted proteins and polynucleotides encoding them
06/10/1999CA2312195A1 Low-voltage activated calcium channel compositions and methods
06/10/1999CA2312050A1 Proteinase inhibitor fusion proteins
06/10/1999CA2312048A1 Human thyroid protein zsig45 and dna encoding same
06/10/1999CA2312029A1 Cloning method by multiple digestion, vectors for implementing same and applications
06/10/1999CA2312009A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
06/10/1999CA2312007A1 Methods and means for inducing apoptosis by interfering with bip-like proteins
06/10/1999CA2312002A1 Human rnase h and compositions and uses thereof
06/10/1999CA2311954A1 Process for measuring apoptosis
06/10/1999CA2311927A1 Identification and characterization of interacting molecules
06/10/1999CA2311705A1 Identification and characterization of interacting molecules by automated interaction mating
06/10/1999CA2311680A1 Cancer susceptibility mutations of brca2
06/10/1999CA2311647A1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999CA2311640A1 Polypeptides and nucleic acids encoding the same
06/10/1999CA2311611A1 Molecules interacting with apoptin
06/10/1999CA2311598A1 Dna encoding phage resistance protein
06/10/1999CA2311574A1 Cells expressing anti-fc receptor binding components
06/10/1999CA2311571A1 Isolation and characterization of plant regulatory sequences
06/10/1999CA2311429A1 Method and device for disintegrating biological cells for the purpose of extracting and analyzing cell contents
06/10/1999CA2311414A1 Diagnostic method, diagnostic reagent and therapeutic preparation for diseases caused by variation in lkb1 gene
06/10/1999CA2311282A1 Yac vectors
06/10/1999CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999CA2309810A1 Erythropoietin with high specific activity
06/10/1999CA2309534A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/10/1999CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/09/1999EP0921395A2 Assays for measurement of protein fragments in biological media
06/09/1999EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene
06/09/1999EP0921196A1 Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
06/09/1999EP0921195A1 Antisense base sequences
06/09/1999EP0921194A2 TRAILLK-2: a member of the TNF ligand family
06/09/1999EP0921193A1 Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy
06/09/1999EP0921192A1 Molecules interacting with apoptin
06/09/1999EP0921191A1 Genetically engineered modification of potato to form amylopectin-type starch
1 ... 3391 3392 3393 3394 3395 3396 3397 3398 3399 3400 3401 3402 3403 3404 3405 3406 3407 3408 3409 3410 3411 ... 4023